9K2K
 
 | | Structure of ClpP from Staphylococcus aureus in complex with ZY7 | | Descriptor: | (6~{S},9~{a}~{S})-6-(2-methylpropyl)-8-(naphthalen-1-ylmethyl)-4,7-bis(oxidanylidene)-~{N}-(phenylmethyl)-3,6,9,9~{a}-tetrahydro-2~{H}-pyrazino[1,2-a]pyrimidine-1-carboxamide, ATP-dependent Clp protease proteolytic subunit | | Authors: | Li, J.H, Wu, W, Zhang, T, Yang, C.-G. | | Deposit date: | 2024-10-17 | | Release date: | 2025-02-19 | | Method: | X-RAY DIFFRACTION (2.74 Å) | | Cite: | Structure-Guided Development of ClpP Agonists with Potent Therapeutic Activities against Staphylococcus aureus Infection.
J.Med.Chem., 68, 2025
|
|
9K2A
 | | Structure of ClpP from Staphylococcus aureus in complex with ZY27 | | Descriptor: | (4S)-2-METHYL-2,4-PENTANEDIOL, (6~{S},9~{a}~{S})-6-(3-azidopropyl)-8-(naphthalen-1-ylmethyl)-4,7-bis(oxidanylidene)-~{N}-[4,4,4-tris(fluoranyl)butyl]-3,6,9,9~{a}-tetrahydro-2~{H}-pyrazino[1,2-a]pyrimidine-1-carboxamide, ATP-dependent Clp protease proteolytic subunit, ... | | Authors: | Wei, B.Y, Wang, P.Y, Wu, W, Zhang, T, Yang, C.-G. | | Deposit date: | 2024-10-17 | | Release date: | 2025-02-19 | | Method: | X-RAY DIFFRACTION (2.19 Å) | | Cite: | Structure-Guided Development of ClpP Agonists with Potent Therapeutic Activities against Staphylococcus aureus Infection.
J.Med.Chem., 68, 2025
|
|
9K2B
 | | Structure of ClpP from Staphylococcus aureus in complex with ZY18 | | Descriptor: | (4S)-2-METHYL-2,4-PENTANEDIOL, (6~{S},9~{a}~{S})-6-[(2~{S})-butan-2-yl]-~{N}-[(2~{S})-2-methylbutyl]-8-(naphthalen-1-ylmethyl)-4,7-bis(oxidanylidene)-3,6,9,9~{a}-tetrahydro-2~{H}-pyrazino[1,2-a]pyrimidine-1-carboxamide, ATP-dependent Clp protease proteolytic subunit, ... | | Authors: | Wei, B.Y, Wang, P.Y, Wu, W, Zhang, T, Yang, C.-G. | | Deposit date: | 2024-10-17 | | Release date: | 2025-02-19 | | Method: | X-RAY DIFFRACTION (2.45 Å) | | Cite: | Structure-Guided Development of ClpP Agonists with Potent Therapeutic Activities against Staphylococcus aureus Infection.
J.Med.Chem., 68, 2025
|
|
9K2D
 | | Structure of ClpP from Staphylococcus aureus in complex with ZY39 | | Descriptor: | (4S)-2-METHYL-2,4-PENTANEDIOL, (6~{S},9~{a}~{S})-6-[(2~{S})-butan-2-yl]-8-[(4-methoxynaphthalen-1-yl)methyl]-4,7-bis(oxidanylidene)-~{N}-[4,4,4-tris(fluoranyl)butyl]-3,6,9,9~{a}-tetrahydro-2~{H}-pyrazino[1,2-a]pyrimidine-1-carboxamide, ATP-dependent Clp protease proteolytic subunit | | Authors: | Wei, B.Y, Wang, P.Y, Wu, W, Zhang, T, Yang, C.-G. | | Deposit date: | 2024-10-17 | | Release date: | 2025-02-19 | | Method: | X-RAY DIFFRACTION (1.98 Å) | | Cite: | Structure-Guided Development of ClpP Agonists with Potent Therapeutic Activities against Staphylococcus aureus Infection.
J.Med.Chem., 68, 2025
|
|
9K2C
 | | Structure of ClpP from Staphylococcus aureus in complex with ZY1 | | Descriptor: | (4S)-2-METHYL-2,4-PENTANEDIOL, (6~{S},9~{a}~{S})-6-(1~{H}-imidazol-5-ylmethyl)-8-(naphthalen-1-ylmethyl)-4,7-bis(oxidanylidene)-~{N}-(phenylmethyl)-3,6,9,9~{a}-tetrahydro-2~{H}-pyrazino[1,2-a]pyrimidine-1-carboxamide, ATP-dependent Clp protease proteolytic subunit, ... | | Authors: | Li, J.H, Wu, W, Zhang, T, Yang, C.-G. | | Deposit date: | 2024-10-17 | | Release date: | 2025-02-19 | | Method: | X-RAY DIFFRACTION (1.98 Å) | | Cite: | Structure-Guided Development of ClpP Agonists with Potent Therapeutic Activities against Staphylococcus aureus Infection.
J.Med.Chem., 68, 2025
|
|
